Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Real-world immunotherapy biomarker testing patterns and results for patients with advanced gastroesophageal cancers in the United States.
Authors
Rutika Mehta
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
Rutika Mehta , Astra M. Liepa , Shen Zheng , Anindya Chatterjee
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
DOI
10.1200/JCO.2022.40.4_suppl.255
Abstract #
255
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using 18F-BMS-986229 PET.
First Author: Samuel Louis Cytryn
Poster
2023 ASCO Annual Meeting
Cemiplimab for kidney organ transplant recipients with advanced cutaneous squamous cell carcinoma: CONTRAC-1.
First Author: Glenn J. Hanna
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Tumor mutational burden as a potential predictive marker for the efficacy of immunotherapy in advanced gastric cancer.
First Author: Jae Yeon Jang
Poster
2022 ASCO Annual Meeting
Effect of immunotherapy and time-of-day infusion chronomodulation on survival in advanced cancers.
First Author: Blessie Elizabeth Nelson